부산대학교 도서관

Timed artificial insemination (TAI) protocols use PGF2α and GnRH injections to synchronize ovulation. The objective was to evaluate the PGPG protocol (d 0, PGF2α; d 3, GnRH; d 11, PGF2α; d 13, GnRH and TAI) for first TAI and also examine methods for second TAI in nonpregnant cows. A factorial test of the first PGF2α, and first GnRH injections within the PGPG protocol was performed (the last PGF2α and GnRH injections were deemed essential to the TAI). Lactating dairy cows (n = 804) in a commercial herd were assigned to 1 of 5 first-TAI treatments, which were PGPG, GPG (d 0, no treatment; d 3, GnRH; d 11, PGF2α; d 13, GnRH and TAI), PPG (d 0, PGF2α; d 3, no treatment; d 11, PGF2α; d 13, GnRH and TAI), and PG (d 0, no treatment; d 3, no treatment; d 11, PGF2α; d 13, GnRH and TAI); the Ovsynch protocol (GnRH, 7 d, PGF2α, 2 d, GnRH and TAI) was the positive control. For resynchronization, cows received either GnRH or the control (no injection) on d 22 after TAI. Nonpregnant cows on d 28 were then treated with PGF2α, on d 29, GnRH on d 31, and TAI [i.e., resynchronization treatments of ReGPG (received GnRH on d 22) and RePG (did not receive GnRH on d 22)]. Pregnancy rates for PGPG, GPG, PPG, PG, and Ovsynch were similar at d 28 after first TAI. Analyses of multiple explanatory factors by logistic regression detected an effect of uterine or ovarian abnormality on the d-28 pregnancy rate (normal more likely to be pregnant). Day-42 pregnancy rates were affected by uterine or ovarian abnormality (normal more likely to be pregnant), postpartum disease occurrence (healthy cows more likely to be pregnant), milk production, and days in milk. Treatment was not significant for the d-42 pregnancy rate. Effects of postpartum disease, milk production, and days in milk on the d-42 pregnancy rate were apparently manifested through their effects on embryonic loss between d 28 and 42 of pregnancy. High-producing cows that received TAI early postpartum were most likely to experience embryonic loss. Day-42 pregnancy rates after the resynchronization treatment were affected by an interaction of the first synchronization treatment with the resynchronization treatment. We concluded that although PGPG can be used for TAI, a simpler TAI protocol that includes the last 2 injections (PGF2α, 2 d; GnRH and TAI) would be equally effective. [ABSTRACT FROM AUTHOR]